Robert Wiseman Dairies has today (14 November) established a joint venture company with milk firm A2 Corp.
Wiseman will invest GBP2m (US$3.2m) to develop a range of A2 milk products aimed at people who find milk hard to digest. The products will go on sale next summer.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Robert Wiseman Dairies said most fresh milk in the UK contains two main types of beta-casein protein, A2 and A1. However, A2 milk comes from cows which naturally produce the A2 type of beta-casein protein rather than the A1, which can cause digestion problems.
A spokesperson for Wiseman said: “We hope that by introducing it in the UK, many people can enjoy the benefits of dairy without the discomfort.
“Around about 20% of people in Western countries believe they are intolerant of dairy and experience discomfort following the consumption of milk. By contrast, however, the NHS estimates that only about 5% of the population is medically diagnosed as lactose intolerant.”
A2 milk is already on sale in Australia and the spokesperson said it was one of the fastest grocery lines in the country, with 85% of people who trial the product go on to buy it again.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataWiseman will own 50% of the new company, which is as yet unnamed, while A2 Corp. will own the remaining 50%. The milk will be processed at Wiseman’s dairy in Droitwich near Birmingham. A search for a chief executive for the venture is underway.
New Zealand dairy firm A2 Corp is constructing a processing facility in south west Sydney to support its growth. It is listed on the New Zealand Stock Exchange.
